Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

A Open-label, Long-term Extension Study of KUC-7483 in Patients With Overactive Bladder

Status

Withdrawn

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01003405

Enrollment

100

Registered

2009-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2010-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Keywords

Overactive bladder, Frequency, Micturition, Urgency, Urge urinary incontinence, OAB

Brief summary

To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.

Interventions

DRUGKUC-7483

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who have successfully completed the Phase III double-blind study.

Exclusion criteria

* Patients with serious adverse events or clinically significant adverse events in the Phase III double-blind study.

Design outcomes

Primary

Measure	Time frame
The long-term safety of KUC-7483 for the treatment of overactive bladder.	52 weeks

Secondary

Measure	Time frame
The long-term efficacy of KUC-7483 for the treatment of overactive bladder.	52 weeks

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026